Epilepsy and lockdown: A survey of patients normally attending a Spanish centre.
Acta Neurol Scand
; 143(2): 206-209, 2021 Feb.
Article
in English
| MEDLINE | ID: covidwho-1388169
ABSTRACT
BACKGROUND:
Lockdown due to the SARS-CoV-2 pandemic became a challenge to maintain care for patients with epilepsy; we aimed to find out how the pandemic affected them.METHODS:
We sent an online 22-item questionnaire to patients from our outpatient clinic, a reference centre in Spain for drug-resistant epilepsy, inquiring about the effects of lockdown, from March to May 2020.RESULTS:
We sent the survey to 627 patients; 312 (58% women) sent a complete response and were included. Of all respondents, 57% took >2 antiseizure medications. One-third of respondents (29%) declared an associated cognitive or motor disability. A minority had confirmed infection with SARS-CoV-2 (1.92%). Seizure frequency remained like usual in 56% of patients, while 31.2% reported an increase. Less than 10% needed emergent assistance. Almost half reported anxiety or depression, and 25% increased behavioural disorders. Mood (F 5.40; p 0.002) and sleep disorders (F = 2.67; p 0.05) were associated with increase in seizure frequency. Patients were able to contact their physicians when needed and were open to a future telematic approach to follow-up visits.CONCLUSIONS:
Seizure frequency and severity remained unchanged in most patients during the lockdown. Mood and sleep disorders were common and associated with seizure worsening. Patients were open to telematic care in the future.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Quarantine
/
Epilepsy
/
Pandemics
/
COVID-19
Type of study:
Cohort study
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
English
Journal:
Acta Neurol Scand
Year:
2021
Document Type:
Article
Affiliation country:
ANE.13354
Similar
MEDLINE
...
LILACS
LIS